Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 216,135,328
  • Shares Outstanding, K 5,960,710
  • Annual Sales, $ 52,546 M
  • Annual Income, $ 21,308 M
  • 36-Month Beta 0.94
  • Price/Sales 4.05
  • Price/Cash Flow 10.21
  • Price/Book 3.48

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.20 +9.22%
on 02/09/18
39.43 -8.04%
on 01/29/18
-0.34 (-0.93%)
since 01/16/18
3-Month
33.20 +9.22%
on 02/09/18
39.43 -8.04%
on 01/29/18
+0.70 (+1.97%)
since 11/16/17
52-Week
31.67 +14.49%
on 06/08/17
39.43 -8.04%
on 01/29/18
+2.64 (+7.85%)
since 02/16/17

Most Recent Stories

More News
Stocks stretch winning streak to 6 days despite turbulence

NEW YORK (AP) — Stocks closed out their strongest week in five years Friday and have now recovered more than half of the losses they suffered in a plunge at the beginning of the month.

VFC : 74.64 (-11.08%)
CPB : 46.17 (-3.21%)
WFC : 59.95 (-0.12%)
JNJ : 133.15 (+1.46%)
HD : 186.97 (+0.92%)
PFE : 36.26 (+1.54%)
Pfizer Inc Rises 1.57% on Heavy Volume: Watch For Potential Pullback

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $35.68 to a high of $36.33. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $35.73...

PFE : 36.26 (+1.54%)
SmarTrend Watching for Potential Pullback in Shares of Pfizer Inc After 1.57% Gain

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $35.68 to a high of $36.33. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $35.73...

PFE : 36.26 (+1.54%)
Bristol-Myers Squibb (BMY) in Focus: Stock Moves 5.6% Higher

Bristol-Myers Squibb (BMY) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

PFE : 36.26 (+1.54%)
BMY : 68.96 (-0.03%)
FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments

FDA's proposed guidelines come in a week when major disappointments in the field were announced by companies developing drugs to treat Alzheimer's.

MRK : 56.29 (+0.54%)
LLY : 78.97 (+1.22%)
PFE : 36.26 (+1.54%)
BIIB : 291.87 (-2.51%)
Breakthrough Anti-cancer Drug Candidates Targeting Potential Best-in-class Therapies for 2018

MarketNewsUpdates.com News Commentary

VRX.TO : 23.70 (+1.63%)
DBVT : 25.86 (-1.11%)
VRX : 18.88 (+1.12%)
PFE : 36.26 (+1.54%)
MBRX : 2.07 (-26.07%)
NKTR : 83.43 (+1.57%)
BMY : 68.96 (-0.03%)
Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

DARMSTADT, Germany and NEW YORK, February 15, 2018 /PRNewswire/ --

MRK : 56.29 (+0.54%)
PFE : 36.26 (+1.54%)
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or...

PFE : 36.26 (+1.54%)
MKKGY : 20.8600 (+0.29%)
Free Research Reports on These Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on IPXL, MRK, NVS, and PFE which can be accessed for free by signing up to www.wallstequities.com/registration....

MRK : 56.29 (+0.54%)
IPXL : 19.60 (+1.03%)
NVS : 86.91 (+0.27%)
PFE : 36.26 (+1.54%)
Exelixis Reports Positive Data From Thyroid Carcinoma Trial

Exelixis (EXEl) announces positive data from a phase II trial of cabozantinib for the first-line treatment of metastatic radioiodine-refractory differentiated thyroid carcinoma.

EXEL : 29.18 (-2.01%)
RHHBY : 30.3000 (-0.36%)
PFE : 36.26 (+1.54%)
BMY : 68.96 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 37.18
1st Resistance Point 36.72
Last Price 36.26
1st Support Level 35.74
2nd Support Level 35.22

See More

52-Week High 39.43
Fibonacci 61.8% 36.47
Last Price 36.26
Fibonacci 50% 35.55
Fibonacci 38.2% 34.63
52-Week Low 31.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.